CHICAGO (GenomeWeb) – BC Platforms, a Swiss genomic data management company, announced today that it has raised $10 million in a Series B funding round. The Debiopharm Innovation Fund, of Lausanne, Switzerland, and Finnish private equity company Tesi led the investment.

BC Platforms said it plans on using the funding in part to add a clinical component this year to its existing software for genomic data management. The company has a goal of managing genomic and clinical data of at least 5 million people by 2020, drawn from biobanks around the world.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.

Jun
12
Sponsored by
Philips Genomics

This webinar will highlight a comprehensive end-to-end solution for precision care in oncology, comprising sample acquisition through to sequencing and analysis, treatment recommendations, and follow-through.